“…7,8 Extracorporeal membrane oxygenation (ECMO) may be considered in the care of infants and children with severe respiratory and cardiac failure refractory to other therapies. 9 The indications for ECMO are evolving as outcomes improve and new therapies are developed for the underlying diseases. However, ECMO is typically used in patients with acute reversible disease processes and, historically, HLH patients would not be considered appropriate candidates.…”
HLH is an uncommon indication for ECMO and these patients have increased mortality compared to the overall pediatric ECMO population. These data should be factored into decision-making when considering ECMO for pediatric HLH patients.
“…7,8 Extracorporeal membrane oxygenation (ECMO) may be considered in the care of infants and children with severe respiratory and cardiac failure refractory to other therapies. 9 The indications for ECMO are evolving as outcomes improve and new therapies are developed for the underlying diseases. However, ECMO is typically used in patients with acute reversible disease processes and, historically, HLH patients would not be considered appropriate candidates.…”
HLH is an uncommon indication for ECMO and these patients have increased mortality compared to the overall pediatric ECMO population. These data should be factored into decision-making when considering ECMO for pediatric HLH patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.